Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 8 January 2009. doi:10.1136/tc.2008.027466
Tobacco Control 2009;18:138-143
Copyright © 2009 by the BMJ Publishing Group Ltd.

RESEARCH PAPERS

Economic cost of tobacco use in India, 2004

R M John1, H-Y Sung2, W Max2

1 University of Illinois at Chicago, Institute for Health Research and Policy, Chicago, Illinois, USA
2 University of California San Francisco, San Francisco, California, USA

R M John, University of Illinois at Chicago, Institute for Health Research and Policy (MC 275), 1747 West Roosevelt Road, Room 558, Chicago, Illinois 60608, USA; rmjohn{at}uic.edu

Objective: To estimate the tobacco-attributable costs of diseases separately for smoked and smokeless tobacco use in India.

Methods: The prevalence-based attributable-risk approach was used to estimate the economic cost of tobacco using healthcare expenditure data from the National Sample Survey, a nationally representative household sample survey conducted in India in 2004. Four major categories of tobacco-related disease—tuberculosis, respiratory diseases, cardiovascular diseases and neoplasms—were considered.

Results: Direct medical costs of treating tobacco related diseases in India amounted to $907 million for smoked tobacco and $285 million for smokeless tobacco. The indirect morbidity costs of tobacco use, which includes the cost of caregivers and value of work loss due to illness, amounted to $398 million for smoked tobacco and $104 million for smokeless tobacco. The total economic cost of tobacco use amounted to $1.7 billion. Tuberculosis accounted for 18% of tobacco-related costs ($311 million) in India. Of the total cost of tobacco, 88% was attributed to men.

Conclusions: The cost of tobacco use was many times more than the expenditures on tobacco control by the government of India and about 16% more than the total tax revenue from tobacco. The tobacco-attributable cost of tuberculosis was three times higher than the expenditure on tuberculosis control in India. The economic costs estimated here do not include the costs of premature mortality from tobacco use, which is known to comprise roughly 50% to 80% of the total economic cost of tobacco in many countries.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.